Literature DB >> 19107350

Image-guided radiotherapy for prostate cancer. Implementation of ultrasound-based prostate localization for the analysis of inter- and intrafraction organ motion.

Michael Pinkawa1, Martin Pursch-Lee, Branka Asadpour, Bernd Gagel, Marc D Piroth, Jens Klotz, Sandra Nussen, Michael J Eble.   

Abstract

PURPOSE: To evaluate inter- and intrafraction organ motion with an ultrasound-based prostate localization system (BAT) for patients treated with intensity-modulated radiotherapy for prostate cancer. PATIENTS AND METHODS: After set-up to external skin marks, 260/219 ultrasound-based alignments were performed before/after irradiation in 32 consecutive patients. Image quality was classified as good, satisfactory or poor. Patient- and imaging-related parameters were analyzed to identify predictors for poor image quality. Shifts in relation to the treatment planning computed tomography (CT) were recorded before/after irradiation in the superior-inferior (SI), anterior-posterior (AP) and right-left (RL) directions to determine inter-/intrafraction prostate motion.
RESULTS: The thickness of tissue anterior to the bladder and bladder volume during the ultrasound localization as well as an inferior prostate position relative to public symphysis (determined in treatment planning CT) were found to be independent predictors of a poor image quality. Interfraction shifts (mean+/-standard deviation: -0.2+/-4.8 [SI], 2.4+/-6.6 [AP] and 1.9+/-4.6 [RL]) varied much stronger than intrafraction shifts (0.0+/-2.0 [SI], 0.6+/-2.2 [AP] and 0.2+/-1.9 [RL]). A larger pressure of the ultrasound probe (determined as a larger reduction of the distance abdominal skin to prostate between the planning CT and the ultrasound) was applied in case of poor image quality, associated with larger systematic posterior prostate displacements.
CONCLUSION: Intrafraction prostate shifts are considerably smaller in comparison to interfraction shifts. Bladder filling and a small pressure on the ultrasound probe are crucial to achieve an adequate image quality without systematic prostate displacements.

Entities:  

Mesh:

Year:  2008        PMID: 19107350     DOI: 10.1007/s00066-008-1902-7

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  27 in total

1.  [Dosimetric impact of image-guided translational isocenter correction for 3-D conformal radiotherapy of the prostate].

Authors:  Hansjoerg Wertz; Frank Lohr; Barbara Dobler; Sabine Mai; Frederik Wenz
Journal:  Strahlenther Onkol       Date:  2007-04       Impact factor: 3.621

2.  Postoperative radiotherapy for prostate cancer : evaluation of target motion and treatment techniques (intensity-modulated versus conformal radiotherapy).

Authors:  Michael Pinkawa; Jaroslav Siluschek; Bernd Gagel; Marc D Piroth; Cengiz Demirel; Branka Asadpour; Michael J Eble
Journal:  Strahlenther Onkol       Date:  2007-01       Impact factor: 3.621

3.  A comparison of the use of bony anatomy and internal markers for offline verification and an evaluation of the potential benefit of online and offline verification protocols for prostate radiotherapy.

Authors:  Helen A McNair; Vibeke N Hansen; Christopher C Parker; Phil M Evans; Andrew Norman; Elizabeth Miles; Emma J Harris; Louise Del-Acroix; Elizabeth Smith; Richard Keane; Vincent S Khoo; Alan C Thompson; David P Dearnaley
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-11-08       Impact factor: 7.038

4.  Individualized planning target volumes for intrafraction motion during hypofractionated intensity-modulated radiotherapy boost for prostate cancer.

Authors:  Patrick Cheung; Katharina Sixel; Gerard Morton; D Andrew Loblaw; Romeo Tirona; Geordi Pang; Richard Choo; Ewa Szumacher; Gerrit Deboer; Jean-Philippe Pignol
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-06-01       Impact factor: 7.038

5.  Influence of the initial rectal distension on posterior margins in primary and postoperative radiotherapy for prostate cancer.

Authors:  Michael Pinkawa; Jaroslav Siluschek; Bernd Gagel; Cengiz Demirel; Branka Asadpour; Richard Holy; Michael J Eble
Journal:  Radiother Oncol       Date:  2006-11-27       Impact factor: 6.280

6.  Late rectal bleeding after conformal radiotherapy of prostate cancer. II. Volume effects and dose-volume histograms.

Authors:  A Jackson; M W Skwarchuk; M J Zelefsky; D M Cowen; E S Venkatraman; S Levegrun; C M Burman; G J Kutcher; Z Fuks; S A Liebel; C C Ling
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-03-01       Impact factor: 7.038

7.  Initial experience with ultrasound localization for positioning prostate cancer patients for external beam radiotherapy.

Authors:  Christopher F Serago; Suzanne J Chungbin; Steven J Buskirk; Gary A Ezzell; A Craig Collie; Sujay A Vora
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-08-01       Impact factor: 7.038

Review 8.  Risk of second malignancies after prostate irradiation?

Authors:  Arndt-Christian Müller; Ute Ganswindt; Michael Bamberg; Claus Belka
Journal:  Strahlenther Onkol       Date:  2007-11       Impact factor: 3.621

9.  Organ movements and dose exposures in teletherapy of prostate cancer using a rectal balloon.

Authors:  Hassan Elsayed; Tobias Bölling; Christos Moustakis; Stefan-Bodo Müller; Patrick Schüller; Iris Ernst; Normann Willich; Stefan Könemann
Journal:  Strahlenther Onkol       Date:  2007-11       Impact factor: 3.621

10.  Variability of bladder filling in patients receiving radical radiotherapy to the prostate.

Authors:  Una M O'Doherty; Helen A McNair; Andrew R Norman; Elizabeth Miles; Simon Hooper; Mark Davies; Naomi Lincoln; Jan Balyckyi; Peter Childs; David P Dearnaley; Robert A Huddart
Journal:  Radiother Oncol       Date:  2006-06-16       Impact factor: 6.280

View more
  25 in total

1.  Numerical deconvolution to enhance sharpness and contrast of portal images for radiotherapy patient positioning verification.

Authors:  H K Looe; Y Uphoff; D Harder; B Poppe; K C Willborn
Journal:  Strahlenther Onkol       Date:  2012-01-12       Impact factor: 3.621

2.  Current role of spacers for prostate cancer radiotherapy.

Authors:  Michael Pinkawa
Journal:  World J Clin Oncol       Date:  2015-12-10

3.  Postoperative radiotherapy for advanced prostate cancer: improved local control translates into increased survival.

Authors:  Marie-Luise Sautter-Bihl; Felix Sedlmayer; Thomas Wiegel
Journal:  Strahlenther Onkol       Date:  2009-08       Impact factor: 3.621

4.  Linearity of patient positioning detection : a phantom study of skin markers, cone beam computed tomography, and 3D ultrasound.

Authors:  Hendrik Ballhausen; Sheila Hieber; Minglun Li; Katia Parodi; Claus Belka; Michael Reiner
Journal:  Strahlenther Onkol       Date:  2015-01-30       Impact factor: 3.621

5.  Comparing morbidity and cancer control after 3D-conformal (70/74 Gy) and intensity modulated radiotherapy (78/82 Gy) for prostate cancer.

Authors:  Martin Dolezel; Karel Odrazka; Milan Zouhar; Miloslava Vaculikova; Jana Sefrova; Jan Jansa; Petr Paluska; Tereza Kohlova; Jaroslav Vanasek; Josef Kovarik
Journal:  Strahlenther Onkol       Date:  2015-01-15       Impact factor: 3.621

6.  Evaluation of uterine ultrasound imaging in cervical radiotherapy; a comparison of autoscan and conventional probe.

Authors:  Mariwan Baker; David T Cooper; Claus F Behrens
Journal:  Br J Radiol       Date:  2016-07-25       Impact factor: 3.039

7.  Dose escalation in prostate radiotherapy up to 82 Gy using simultaneous integrated boost: direct comparison of acute and late toxicity with 3D-CRT 74 Gy and IMRT 78 Gy.

Authors:  Martin Dolezel; Karel Odrazka; Miloslava Vaculikova; Jaroslav Vanasek; Jana Sefrova; Petr Paluska; Milan Zouhar; Jan Jansa; Zuzana Macingova; Lida Jarosova; Milos Brodak; Petr Moravek; Igor Hartmann
Journal:  Strahlenther Onkol       Date:  2010-03-26       Impact factor: 3.621

8.  Intensity-modulated radiotherapy of prostate cancer with simultaneous integrated boost after molecular imaging with 18F-choline-PET/CT : Clinical results and quality of life.

Authors:  Marsha Schlenter; Vanessa Berneking; Barabara Krenkel; Felix M Mottaghy; Thomas-Alexander Vögeli; Michael J Eble; Michael Pinkawa
Journal:  Strahlenther Onkol       Date:  2018-03-06       Impact factor: 3.621

9.  Consequential late effects after radiotherapy for prostate cancer - a prospective longitudinal quality of life study.

Authors:  Michael Pinkawa; Richard Holy; Marc D Piroth; Karin Fischedick; Sandra Schaar; Dalma Székely-Orbán; Michael J Eble
Journal:  Radiat Oncol       Date:  2010-04-08       Impact factor: 3.481

10.  Moderate dose escalation in three-dimensional conformal localized prostate cancer radiotherapy: single-institutional experience in 398 patients comparing 66 Gy versus 70 Gy versus 74 Gy.

Authors:  Gregor Goldner; Johannes Dimopoulos; Christian Kirisits; Richard Pötter
Journal:  Strahlenther Onkol       Date:  2009-08-28       Impact factor: 3.621

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.